These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31601578)

  • 1. Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis.
    Solo K; Lavi S; Kabali C; Levine GN; Kulik A; John-Baptiste AA; Fremes SE; Martin J; Eikelboom JW; Ruel M; Huitema AA; Choudhury T; Bhatt DL; Tzemos N; Mamas MA; Bagur R
    BMJ; 2019 Oct; 367():l5476. PubMed ID: 31601578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
    Sandner S; Redfors B; Angiolillo DJ; Audisio K; Fremes SE; Janssen PWA; Kulik A; Mehran R; Peper J; Ruel M; Saw J; Soletti GJ; Starovoytov A; Ten Berg JM; Willemsen LM; Zhao Q; Zhu Y; Gaudino M
    JAMA; 2022 Aug; 328(6):554-562. PubMed ID: 35943473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy in patients receiving saphenous vein coronary artery bypass grafts: a protocol for a systematic review and network meta-analysis.
    Solo K; Martin J; Lavi S; Kabali C; John-Baptiste A; Nevis IF; Choudhury T; Mamas MA; Bagur R
    BMJ Open; 2018 Apr; 8(4):e019555. PubMed ID: 29627809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery.
    Hesterberg K; Rawal A; Khan S; Rashid A; Jones D; Siddiqui T; Khader TA; Nayyar M; Shah R
    Cardiovasc Revasc Med; 2020 Jun; 21(6):792-796. PubMed ID: 31672535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysis.
    Gupta S; Belley-Cote EP; Panchal P; Pandey A; Basha A; Pallo L; Rochwerg B; Mehta S; Schwalm JD; Whitlock RP
    Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):354-363. PubMed ID: 32772110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
    JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic strategies for preventing graft failure in coronary artery bypass graft.
    Mauro MS; Finocchiaro S; Calderone D; Rochira C; Agnello F; Scalia L; Capodanno D
    J Thromb Thrombolysis; 2024 Apr; 57(4):547-557. PubMed ID: 38491265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial.
    Sandner S; Gaudino M; Redfors B; Angiolillo DJ; Ben-Yehuda O; Bhatt DL; Fremes SE; Lamy A; Marano R; Mehran R; Pocock S; Rao SV; Spertus JA; Weinsaft JW; Wells G; Ruel M
    EuroIntervention; 2024 Mar; 20(5):e322-e328. PubMed ID: 38436365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
    Dörffler-Melly J; Büller HR; Koopman MM; Prins MH
    Cochrane Database Syst Rev; 2003; (4):CD000536. PubMed ID: 14583924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor for patients undergoing coronary artery bypass grafting: A meta-analysis of randomized controlled trials.
    Xiang F; Lin Y; Chen B
    Perfusion; 2023 May; 38(4):698-705. PubMed ID: 35403510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy and coronary artery bypass grafting: Protocol for a systematic review and network meta-analysis.
    Gupta S; Belley-Côté EP; Rochwerg B; Bozzo A; Panchal P; Pandey A; Mbuagbaw L; Mehta S; Schwalm JD; Whitlock RP
    Medicine (Baltimore); 2019 Aug; 98(34):e16880. PubMed ID: 31441862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Different Chronic Maintenance Antithrombotic Strategies in Patients with Coronary Artery Disease: A Systematic Review and Network Meta-Analysis.
    Zhang J; Chen Z; Cai Y; Li C; He Y
    Cardiovasc Ther; 2023; 2023():5446271. PubMed ID: 37636560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety outcomes of anti-platelet therapy post coronary artery bypass graft surgery: A systematic review and network meta-analysis of randomized control trials.
    Hasan SU; Pervez A; Shah AA; Shah SD; Aslam M; Arshad A; Rajput AS; Zubair MM
    Perfusion; 2024 May; 39(4):684-697. PubMed ID: 36803180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: An updated meta-analysis.
    Cardoso R; Knijnik L; Whelton SP; Rivera M; Gluckman TJ; Metkus TS; Blumenthal RS; McEvoy JW
    Int J Cardiol; 2018 Oct; 269():80-88. PubMed ID: 30072154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Long-Term Antithrombotic Strategies in Patients With Chronic Coronary Syndrome: A Network Meta-analysis of Randomized Controlled Trials.
    Zhu H; Xu X; Fang X; Ying F; Song L; Gao B; Tong G; Zhou L; Chen T; Huang J
    J Am Heart Assoc; 2021 Mar; 10(6):e019184. PubMed ID: 33682435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network meta-analysis of antiplatelet therapy following coronary artery bypass grafting (CABG): none versus one versus two antiplatelet agents.
    Chakos A; Jbara D; Singh K; Yan TD; Tian DH
    Ann Cardiothorac Surg; 2018 Sep; 7(5):577-585. PubMed ID: 30505741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Stein PD; Schünemann HJ; Dalen JE; Gutterman D
    Chest; 2004 Sep; 126(3 Suppl):600S-608S. PubMed ID: 15383486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.